157 related articles for article (PubMed ID: 12742081)
1. Neurotoxic and neuroprotective effects of the glutamate transporter inhibitor DL-threo-beta-benzyloxyaspartate (DL-TBOA) during physiological and ischemia-like conditions.
Bonde C; Sarup A; Schousboe A; Gegelashvili G; Zimmer J; Noraberg J
Neurochem Int; 2003; 43(4-5):371-80. PubMed ID: 12742081
[TBL] [Abstract][Full Text] [Related]
2. Ionotropic glutamate receptors and glutamate transporters are involved in necrotic neuronal cell death induced by oxygen-glucose deprivation of hippocampal slice cultures.
Bonde C; Noraberg J; Noer H; Zimmer J
Neuroscience; 2005; 136(3):779-94. PubMed ID: 16344151
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of the substrate inhibitor l-trans-pyrrolidine-2,4-dicarboxylate (PDC) and the non-substrate inhibitor DL-threo-beta-benzyloxyaspartate (DL-TBOA) of glutamate transporters on neuronal damage and extracellular amino acid levels in rat brain in vivo.
Montiel T; Camacho A; Estrada-Sánchez AM; Massieu L
Neuroscience; 2005; 133(3):667-78. PubMed ID: 15890455
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective potential of ceftriaxone in in vitro models of stroke.
Lipski J; Wan CK; Bai JZ; Pi R; Li D; Donnelly D
Neuroscience; 2007 May; 146(2):617-29. PubMed ID: 17363173
[TBL] [Abstract][Full Text] [Related]
5. DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters.
Shimamoto K; Lebrun B; Yasuda-Kamatani Y; Sakaitani M; Shigeri Y; Yumoto N; Nakajima T
Mol Pharmacol; 1998 Feb; 53(2):195-201. PubMed ID: 9463476
[TBL] [Abstract][Full Text] [Related]
6. Transporter reversal as a mechanism of glutamate release from the ischemic rat cerebral cortex: studies with DL-threo-beta-benzyloxyaspartate.
Phillis JW; Ren J; O'Regan MH
Brain Res; 2000 Jun; 868(1):105-12. PubMed ID: 10841893
[TBL] [Abstract][Full Text] [Related]
7. Differing effects of substrate and non-substrate transport inhibitors on glutamate uptake reversal.
Anderson CM; Bridges RJ; Chamberlin AR; Shimamoto K; Yasuda-Kamatani Y; Swanson RA
J Neurochem; 2001 Dec; 79(6):1207-16. PubMed ID: 11752061
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection Promoted by Guanosine Depends on Glutamine Synthetase and Glutamate Transporters Activity in Hippocampal Slices Subjected to Oxygen/Glucose Deprivation.
Dal-Cim T; Martins WC; Thomaz DT; Coelho V; Poluceno GG; Lanznaster D; Vandresen-Filho S; Tasca CI
Neurotox Res; 2016 May; 29(4):460-8. PubMed ID: 26858177
[TBL] [Abstract][Full Text] [Related]
9. Role of the GLT-1 subtype of glutamate transporter in glutamate homeostasis: the GLT-1-preferring inhibitor WAY-855 produces marginal neurotoxicity in the rat hippocampus.
Selkirk JV; Nottebaum LM; Vana AM; Verge GM; Mackay KB; Stiefel TH; Naeve GS; Pomeroy JE; Petroski RE; Moyer J; Dunlop J; Foster AC
Eur J Neurosci; 2005 Jun; 21(12):3217-28. PubMed ID: 16026460
[TBL] [Abstract][Full Text] [Related]
10. Characterization of novel L-threo-beta-benzyloxyaspartate derivatives, potent blockers of the glutamate transporters.
Shimamoto K; Sakai R; Takaoka K; Yumoto N; Nakajima T; Amara SG; Shigeri Y
Mol Pharmacol; 2004 Apr; 65(4):1008-15. PubMed ID: 15044631
[TBL] [Abstract][Full Text] [Related]
11. Transient increase in the high affinity [3H]-L-glutamate uptake activity during in vitro development of hippocampal neurons in culture.
Gaillet S; Plachez C; Malaval F; Bézine MF; Récasens M
Neurochem Int; 2001 Apr; 38(4):293-301. PubMed ID: 11137623
[TBL] [Abstract][Full Text] [Related]
12. GDNF pre-treatment aggravates neuronal cell loss in oxygen-glucose deprived hippocampal slice cultures: a possible effect of glutamate transporter up-regulation.
Bonde C; Sarup A; Schousboe A; Gegelashvili G; Noraberg J; Zimmer J
Neurochem Int; 2003; 43(4-5):381-8. PubMed ID: 12742082
[TBL] [Abstract][Full Text] [Related]
13. Effects of glial glutamate transporter inhibitors on intracellular Na+ in mouse astrocytes.
Chatton JY; Shimamoto K; Magistretti PJ
Brain Res; 2001 Mar; 893(1-2):46-52. PubMed ID: 11222991
[TBL] [Abstract][Full Text] [Related]
14. GMP prevents excitotoxicity mediated by NMDA receptor activation but not by reversal activity of glutamate transporters in rat hippocampal slices.
Molz S; Tharine DC; Decker H; Tasca CI
Brain Res; 2008 Sep; 1231():113-20. PubMed ID: 18655777
[TBL] [Abstract][Full Text] [Related]
15. Histamine up-regulates astrocytic glutamate transporter 1 and protects neurons against ischemic injury.
Fang Q; Hu WW; Wang XF; Yang Y; Lou GD; Jin MM; Yan HJ; Zeng WZ; Shen Y; Zhang SH; Xu TL; Chen Z
Neuropharmacology; 2014 Feb; 77():156-66. PubMed ID: 23791559
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of (2S, 3S)-3-[3-[4-(trifluoromethyl)benzoylamino]benzyloxy]aspartate (TFB-TBOA) on the astrocytic sodium responses to glutamate.
Bozzo L; Chatton JY
Brain Res; 2010 Feb; 1316():27-34. PubMed ID: 20026319
[TBL] [Abstract][Full Text] [Related]
17. Glutamate transporters regulate excitability in local networks in rat neocortex.
Campbell SL; Hablitz JJ
Neuroscience; 2004; 127(3):625-35. PubMed ID: 15283962
[TBL] [Abstract][Full Text] [Related]
18. The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cells.
Pedraz-Cuesta E; Christensen S; Jensen AA; Jensen NF; Bunch L; Romer MU; Brünner N; Stenvang J; Pedersen SF
BMC Cancer; 2015 May; 15():411. PubMed ID: 25981639
[TBL] [Abstract][Full Text] [Related]
19. Gliotoxicity in hippocampal cultures is induced by transportable, but not by nontransportable, glutamate uptake inhibitors.
Guiramand J; Martin A; de Jesus Ferreira MC; Cohen-Solal C; Vignes M; Récasens M
J Neurosci Res; 2005 Jul; 81(2):199-207. PubMed ID: 15931685
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of uptake unmasks rapid extracellular turnover of glutamate of nonvesicular origin.
Jabaudon D; Shimamoto K; Yasuda-Kamatani Y; Scanziani M; Gähwiler BH; Gerber U
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8733-8. PubMed ID: 10411944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
